Skip to main content
. 2017 Dec 27;7(3):147–157. doi: 10.1002/psp4.12270

Table 1.

Physicochemical properties and in vivo doses for selected bases and quaternary amines.

Drug Ion class Solubilitya, µM LogD7.4 b pKa c i.v./i.t. doses in the rat, µg/kg i.v./i.t. doses in the dog, µg/kg
Salmeterol Base >380 2.2 9.1 14/18
Formoterol Base 600 0.49 8.4 15/14 10/5
Salbutamol Base >2,900 −1.9 9.2 1,064/15
Terbutaline Base 6,830 −1.5 9.3 1,038/1080 500/50
Indacaterol Base 25 2.8 8.3 1,000/15
Tiotropium QA >2,800 <‐1.3 NA 10,000/53 80/0.7
Ipratropium QA >9,140 −1.0 NA 1,000/1,002
Glycopyrronium QA >4,050 0.12d NA 282/8.1
AZD2115 Dibase 650 2.1 8.7/7.6 769/6.6
Batefenterol Dibase 28 3.1 10/7.3 597/1.2
AZD4818 Dibase >2,500 0.90 8.4/6.2 258/10.8
AZD3199 Dibase 2,510 2.3 9.5/7.1 1,000/15.7

LogD, logarithm of the distribution coefficient; NA, not applicable; QA, quaternary amine.

a

Solubility in phosphate buffer at pH 7.4, for method see ref. 12.

b

Octanol/water partition coefficient when aqueous phase is at pH7.4, for method see ref. 13.

c

For method, see ref. 14.

ClogP.